• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响接受抗分泌药物治疗的反流性食管炎患者及对照组中嗜银细胞密度和增生的因素。

Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.

作者信息

Diebold M D, Richardson S, Duchateau A, Bigard M A, Colin R, Cortot A, Fauchère J L, Zeitoun P

机构信息

Department of Pathology, Hôpital Robert Debré, Reims, France.

出版信息

Dig Dis Sci. 1998 Aug;43(8):1629-35.

PMID:9724142
Abstract

A cross sectional study was designed to elucidate the factors influencing the argyrophil cell population in patients with gastroesophageal reflux disease treated with omeprazole (N = 201) or H2-receptor antagonists (N = 118) and in control patients (N = 215). Fasting gastrinemia and Helicobacter pylori serology were determined. Gastritis, Helicobacter pylori infection, and argyrophil cell density and hyperplasia were evaluated in gastric biopsies. The argyrophil cell density was higher in both treatment groups than in controls (P = 0.002 and P = 0.051), whereas argyrophil cell hyperplasia was similar in the three groups. According to multivariate analysis, positive Helicobacter pylori serology was an independent parameter that decreased both density and grade of hyperplasia of argyrophil cells. Female gender and hypergastrinemia were independent factors increasing argyrophil cell density and hyperplasia, whereas antisecretory therapy, age and active gastritis were not. In addition, atrophic gastritis independently increased argyrophil cell hyperplasia. The prevalence of atrophic gastritis was significantly higher in Helicobacter pylori-positive than in negative patients and lower in the patients treated long-term with omeprazole than in the other groups.

摘要

一项横断面研究旨在阐明影响接受奥美拉唑治疗的胃食管反流病患者(N = 201)或H2受体拮抗剂治疗的患者(N = 118)以及对照患者(N = 215)中嗜银细胞群体的因素。测定空腹胃泌素血症和幽门螺杆菌血清学。在胃活检中评估胃炎、幽门螺杆菌感染以及嗜银细胞密度和增生情况。两个治疗组的嗜银细胞密度均高于对照组(P = 0.002和P = 0.051),而三组的嗜银细胞增生情况相似。根据多变量分析,幽门螺杆菌血清学阳性是一个独立参数,可降低嗜银细胞的密度和增生程度。女性性别和高胃泌素血症是增加嗜银细胞密度和增生的独立因素,而抗分泌治疗、年龄和活动性胃炎则不是。此外,萎缩性胃炎独立增加嗜银细胞增生。幽门螺杆菌阳性患者中萎缩性胃炎的患病率显著高于阴性患者,长期接受奥美拉唑治疗的患者中萎缩性胃炎的患病率低于其他组。

相似文献

1
Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.影响接受抗分泌药物治疗的反流性食管炎患者及对照组中嗜银细胞密度和增生的因素。
Dig Dis Sci. 1998 Aug;43(8):1629-35.
2
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.用奥美拉唑或胃底折叠术治疗的反流性食管炎患者的萎缩性胃炎和幽门螺杆菌感染
N Engl J Med. 1996 Apr 18;334(16):1018-22. doi: 10.1056/NEJM199604183341603.
3
[Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].[质子泵抑制剂长期治疗对血清胃泌素水平及胃底黏膜的影响。初步结果]
Gastroenterol Clin Biol. 1995 Oct;19(10):811-7.
4
Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis.幽门螺杆菌感染通过诱发萎缩性胃炎抑制反流性食管炎。
Am J Gastroenterol. 1999 Dec;94(12):3468-72. doi: 10.1111/j.1572-0241.1999.01593.x.
5
Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.幽门螺杆菌与奥美拉唑治疗胃食管反流病的疗效
Am J Gastroenterol. 1999 Apr;94(4):884-7. doi: 10.1111/j.1572-0241.1999.982_e.x.
6
[The roles of Helicobacter pylori and pattern of gastritis in the pathogenesis of reflux esophagitis].[幽门螺杆菌的作用及胃炎模式在反流性食管炎发病机制中的作用]
Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2674-8.
7
Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.胃食管交界处的慢性炎症(贲门炎)似乎是与幽门螺杆菌感染及胃食管反流病相关的一项特异性发现。芬兰中部内镜研究组。
Am J Gastroenterol. 1999 Nov;94(11):3175-80. doi: 10.1111/j.1572-0241.1999.01513.x.
8
Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.幽门螺杆菌阳性反流性食管炎患者的胃炎特征
J Gastroenterol Hepatol. 2005 May;20(5):682-7. doi: 10.1111/j.1440-1746.2005.03779.x.
9
[Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].[反流性食管炎;服用奥美拉唑的患者是否需要预防性根除幽门螺杆菌?]
Ned Tijdschr Geneeskd. 1998 Apr 18;142(16):883-5.
10
Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients.老年人反流性食管炎的临床特征:对840例连续患者的研究。
J Am Geriatr Soc. 2006 Oct;54(10):1537-42. doi: 10.1111/j.1532-5415.2006.00899.x.

引用本文的文献

1
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.基于 Zollinger-Ellison 综合征患者研究的对慢性高胃泌素血症和终身质子泵抑制剂治疗的影响/风险的深入了解。
Int J Mol Sci. 2019 Oct 16;20(20):5128. doi: 10.3390/ijms20205128.
2
Safety of the long-term use of proton pump inhibitors.质子泵抑制剂长期使用的安全性。
World J Gastroenterol. 2010 May 21;16(19):2323-30. doi: 10.3748/wjg.v16.i19.2323.